Orbimed
-
Type of investor
-
Based in
New York -
Number of investments
6-10 -
Industry
biotech, medtechVisit website of
Orbimed
Related News
12.02.2025 09:57
vVARDIS secures USD 35 million to accelerate global growth
13.01.2025 12:00
Windward Bio launches with $200 million Series A financing round
16.07.2024 11:55
Asceneuron closes $100 million series C financing round
19.10.2020 15:45
VectivBio secures $110 million to finance Phase III clinical trials
09.01.2020 08:43
Therachon spin-off launches with $35 million investment
09.08.2018 14:31
Therachon Raises $60 Million Mezzanine Financing
09.01.2017 13:07
Therachon Closes Series A Financing and Appoints new CEO
24.11.2015 16:46
ObsEva Closes CHF 60 Million in Series B Financing
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
